File Download

There are no files associated with this item.

  Links for fulltext
     (May Require Subscription)
Supplementary

Article: Focused ultrasound treatment of cervical human papillomavirus infection and squamous intraepithelial lesions: A narrative review

TitleFocused ultrasound treatment of cervical human papillomavirus infection and squamous intraepithelial lesions: A narrative review
Authors
KeywordsCervix
Focused ultrasound
Human papillomavirus
Squamous intraepithelial lesion
Issue Date28-May-2025
PublisherElsevier B.V.
Citation
European Journal of Obstetrics & Gynecology and Reproductive Biology: X, 2025, v. 26 How to Cite?
AbstractFocused ultrasound (FUS) appears to be a promising form of thermal ablation for treatment of cervical lesions, but evidence supporting its use is limited. This review evaluated the efficacy and safety of FUS treatment of cervical human papillomavirus (HPV) infection and squamous intraepithelial lesions (SIL). The overall efficacy of FUS on HPV clearance was 75.0–85.7 % at 3 months, 35.5–77.1 % at 6 months and 64.7–94.1 % at 12 months. Its efficacy on low grade SIL and high grade SIL regression were 83.3–96.8 % and 70.9–96.6 % at 6 months, respectively. Complications were uncommon. FUS appears to be an effective and safe treatment modality for cervical HPV and SIL.
Persistent Identifierhttp://hdl.handle.net/10722/357955
ISSN
2023 Impact Factor: 1.5
2023 SCImago Journal Rankings: 0.527
ISI Accession Number ID

 

DC FieldValueLanguage
dc.contributor.authorCheung, Vincent Y.T.-
dc.date.accessioned2025-07-23T00:30:57Z-
dc.date.available2025-07-23T00:30:57Z-
dc.date.issued2025-05-28-
dc.identifier.citationEuropean Journal of Obstetrics & Gynecology and Reproductive Biology: X, 2025, v. 26-
dc.identifier.issn2590-1613-
dc.identifier.urihttp://hdl.handle.net/10722/357955-
dc.description.abstractFocused ultrasound (FUS) appears to be a promising form of thermal ablation for treatment of cervical lesions, but evidence supporting its use is limited. This review evaluated the efficacy and safety of FUS treatment of cervical human papillomavirus (HPV) infection and squamous intraepithelial lesions (SIL). The overall efficacy of FUS on HPV clearance was 75.0–85.7 % at 3 months, 35.5–77.1 % at 6 months and 64.7–94.1 % at 12 months. Its efficacy on low grade SIL and high grade SIL regression were 83.3–96.8 % and 70.9–96.6 % at 6 months, respectively. Complications were uncommon. FUS appears to be an effective and safe treatment modality for cervical HPV and SIL.-
dc.languageeng-
dc.publisherElsevier B.V.-
dc.relation.ispartofEuropean Journal of Obstetrics & Gynecology and Reproductive Biology: X-
dc.rightsThis work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.-
dc.subjectCervix-
dc.subjectFocused ultrasound-
dc.subjectHuman papillomavirus-
dc.subjectSquamous intraepithelial lesion-
dc.titleFocused ultrasound treatment of cervical human papillomavirus infection and squamous intraepithelial lesions: A narrative review-
dc.typeArticle-
dc.identifier.doi10.1016/j.eurox.2025.100406-
dc.identifier.scopuseid_2-s2.0-105007433518-
dc.identifier.volume26-
dc.identifier.isiWOS:001510470000001-
dc.identifier.issnl2590-1613-

Export via OAI-PMH Interface in XML Formats


OR


Export to Other Non-XML Formats